menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Funding News

Funding News

source image

Bloomberg Quint

1w

read

80

img
dot

Image Credit: Bloomberg Quint

Value Vs Momentum Investing: THIS Market Veteran Prefers One Over The Other — Here's Why

  • S Naren of ICICI Prudential AMC prefers momentum investing over value investing in the current market due to trade deal jitters and first quarter earnings results.
  • He believes that every stock is discovered in the Indian market and sees opportunities where investors are frustrated and hated.
  • Naren advocates for a fiscal push for certain sectors of the economy to accelerate growth, citing the need for interest rate cuts and benefits in industries like two-wheelers, auto, and FMCG.
  • The market veteran views momentum investing as more suitable in late-cycle markets, highlighting the importance of agility and risk management in volatile conditions.

Read Full Article

like

4 Likes

source image

Bloomberg Quint

1w

read

3.2k

img
dot

Image Credit: Bloomberg Quint

Tech Layoffs 2025: Intel Cuts Over 500 Jobs; Joins Google, Microsoft In Latest Wave Of Mass Firings

  • Intel is set to lay off 529 employees at its Oregon campuses as part of a broader restructuring effort to trim expenses and refocus operations amid slowing growth and a shift towards artificial intelligence.
  • Tech layoffs in 2025 have also impacted major companies like Microsoft and Google, with Microsoft planning to cut around 9,100 employees this July and Google implementing layoffs in niche product divisions to reallocate resources for AI development.
  • Amazon has initiated selective job cuts to incorporate AI into more areas of its business, with plans for further reductions especially in customer service, human resources, and software development.
  • The tech industry layoffs are affecting various roles and experience levels, including mid-level developers, engineers, professionals in marketing, legal, and sales departments, as well as teams in gaming and entertainment industries at regional offices.

Read Full Article

like

5 Likes

source image

Bloomberg Quint

1w

read

1.3k

img
dot

Image Credit: Bloomberg Quint

Lodha Developers Can Rally 36% Says Motilal Oswal Maintaining 'Buy'

  • Motilal Oswal reiterates Buy rating for Lodha Developers with a revised target price of Rs 1,870, indicating a 36% potential upside.
  • Lodha Developers has been focusing on expanding into new markets and geographies to enhance its residential business since its FY21 listing.
  • The company's presales are expected to grow at a 20% Compound Annual Growth Rate (CAGR), supported by strong collections and a debt level of 0.2x as of Q4 FY25.
  • Lodha entered Pune, is rapidly expanding, completed a pilot phase in Bengaluru, and acquired a 5.6msf project with a gross development value of Rs 66 billion in FY25.

Read Full Article

like

13 Likes

source image

Medium

1w

read

33

img
dot

Image Credit: Medium

How I Saved $50K by Deleting Unused Features

  • By deleting unused features, the author saved $50,000 in annual expenses and redirected the team's focus.
  • The author assessed the analytics dashboard and found many features with minimal to no user engagement, yet requiring maintenance.
  • Working with the DevOps lead, the author calculated the real cost of each feature based on CPU, storage, and maintenance time.
  • The author communicated with the team and key customers before safe removal of features using a 'feature-toggle' branch to monitor potential issues.

Read Full Article

like

2 Likes

source image

Bloomberg Quint

1w

read

124

img
dot

Image Credit: Bloomberg Quint

Granules Recalls 33,000 Bottles Of Blood Lowering Medication In US

  • Granules India is recalling over 33,000 bottles of Metoprolol Succinate extended-release tablets in the US due to failed dissolution specifications.
  • The recall was initiated by the US-based Granules Pharmaceuticals Inc because the product failed to meet dissolution acceptance criteria in stability studies at the sixth month.
  • The recall is categorized as Class II by the USFDA, indicating that the use of the violative product may lead to temporary or medically reversible health consequences.
  • Shares of Granules India were trading 0.54% down following the announcement of the recall.

Read Full Article

like

6 Likes

source image

Bloomberg Quint

1w

read

858

img
dot

Image Credit: Bloomberg Quint

Union Bank Of India Share Price Dips As Q1 Advances, Deposits Decline

  • Union Bank of India's share price declined nearly 6% as its advances and deposits decreased sequentially in the first quarter of fiscal 2026.
  • In the June quarter, the bank reported a 1% sequential decline in advances, with CASA deposits also decreasing by 5%.
  • On a year-on-year basis, the bank saw growth in both deposits and advances. Total business rose 5% to Rs 22.1 lakh crore.
  • The stock price of Union Bank of India fell 4.83% to Rs 415.15 apiece and traded lower compared to the NSE Nifty 50, with most analysts maintaining a 'buy' rating for the company.

Read Full Article

like

19 Likes

source image

Bloomberg Quint

1w

read

421

img
dot

Image Credit: Bloomberg Quint

TCS Q1 Results On Thursday — Should You Buy, Sell Or Hold Ahead Of Earnings Announcement?

  • Tata Consultancy Services Ltd. is set to release its quarterly results on Thursday.
  • Brokerages have varying opinions on the stock's near-term outlook with price targets ranging from Rs 3,220 to Rs 4,400.
  • Some brokerages have 'buy' ratings and target prices between Rs 3,850 to Rs 4,211, while others suggest 'sell' or 'hold' with targets as low as Rs 3,220.
  • TCS stock declined in the previous quarter despite sector gains, with different analysts assessing valuation, growth convergence, and external factors to determine their recommendations.

Read Full Article

like

24 Likes

source image

Bloomberg Quint

1w

read

63

img
dot

Image Credit: Bloomberg Quint

Buy Or Sell? Kunal Rambhia Recommends Ramky Infra, Aavas Finance, Chola Finance — Check Target Price

  • Kunal Rambhia recommends buying Ramky Infrastructure Ltd., Aavas Financiers Ltd., and Cholamandalam Investment and Finance Co. with specific target prices and stop loss prices.
  • For Ramky Infra, the suggested target price is Rs 640 with a stop loss at Rs 590.
  • Aavas Finance has a target price of Rs 2,100 with a stop loss at Rs 1,950.
  • Chola Finance's target price is Rs 1,650 with a stop loss at Rs 1,490.

Read Full Article

like

3 Likes

source image

Bloomberg Quint

1w

read

607

img
dot

Image Credit: Bloomberg Quint

'Hold' Polycab Shares Maintains Nirmal Bang, Says Execution, Favorable Industry Tailwinds To Drive Growth

  • Nirmal Bang maintains a 'Hold' rating on Polycab shares, citing strong execution and favorable industry tailwinds for growth.
  • Polycab achieved its highest-ever consolidated revenue of ~Rs 224 billion and PAT of Rs 20 billion in FY25, driven by healthy growth in the wires & cables and FMEG businesses.
  • The company strengthened its position in the Indian wires and cables market in FY25, increasing its share of the organized segment to 26-27%, with W&C revenue growing around 20%, surpassing industry growth.
  • Nirmal Bang suggests accumulating Polycab shares on dips for long-term prospects.

Read Full Article

like

21 Likes

source image

Bloomberg Quint

1w

read

175

img
dot

Image Credit: Bloomberg Quint

Vedanta Calls Viceroy Report ‘Malicious... Baseless Allegations’ — Read Full Statement

  • Vedanta Group has refuted a report by Viceroy Research, labeling it as a mix of selective misinformation and baseless accusations designed to harm the group's reputation.
  • The company criticized the report for not seeking a response from Vedanta before publication and claimed it distorted publicly available information to manipulate market sentiment.
  • Vedanta suggested that the timing of the report, just before its annual general meeting, raises suspicions of an attempt to disrupt upcoming corporate initiatives.
  • Despite the negative impact on its shares following the report, Vedanta emphasized its commitment to business growth and cautioned against making investment decisions based on unverified claims.

Read Full Article

like

9 Likes

source image

Eu-Startups

1w

read

197

img
dot

French AI assistant Tandem raises €3.2 million to help “users get things done”

  • Paris-based startup Tandem, known for building in-app AI agents to help users complete tasks, has secured €3.2 million in a Seed round led by Tribe Capital.
  • Tandem aims to simplify user interaction with software by completing tasks for them via AI, eliminating the need for extensive product learning.
  • The company plans to expand its execution layer within apps to more companies, addressing issues such as underused features, time-consuming onboarding, and user drop-off rates.
  • Tandem's AI agent allows users to delegate tasks, automate form-filling, follow guided flows, and receive contextual prompts, resulting in improved activation and reduced support tickets.

Read Full Article

like

11 Likes

source image

Bloomberg Quint

1w

read

896

img
dot

Image Credit: Bloomberg Quint

Laurus Labs, Supriya Lifesciences, Divi’s Labs— DRChoksey's Top Stock Picks In Pharma Pack; Q1 Results Preview

  • Top stock picks in the pharma sector by DRChoksey include Laurus Labs, Supriya Lifesciences, and Divi’s Labs.
  • Pharma Q1 Results Preview: Lupin expected to show double-digit growth with new launches scaling up according to DRChoksey.
  • Indian pharmaceutical market grew by 7.8% YoY in April 2025 driven by improved price realization, modest new launches, and muted volume growth.
  • Although US tariffs on Indian pharmaceutical imports pose uncertainty, the sector has mostly been exempted due to its critical role in the US healthcare system.

Read Full Article

like

13 Likes

source image

Bloomberg Quint

1w

read

149

img
dot

Image Credit: Bloomberg Quint

Mid-Cap Stocks To Buy, Sell, Hold: HPCL, Ramkrishna Forgings, Himadri Speciality Chemical — Check Target Price

  • Mid-cap stocks recommended for investment include HPCL, Ramkrishna Forgings, and Himadri Speciality Chemical by experts Vaishali Parekh and Nirav Asher.
  • HPCL is seen as a top pick for both short term and long term investment, with a suggestion to hold the stock.
  • Himadri Speciality Chemical is advised for holding with a target price range of Rs 650-700 for the long term, as per Parekh.
  • Nirav Asher recommends holding Ramkrishna Forgings for potential upside in the next 2-3 years, known for supplying forged products across various sectors.

Read Full Article

like

7 Likes

source image

Bloomberg Quint

1w

read

9.2k

img
dot

Image Credit: Bloomberg Quint

TCS, Infosys, LTIMindtree, Happiest Minds Among Anand Rathi's Top Stock Picks In IT Sector; Q1 Results Preview

  • Anand Rathi has listed top stock picks in the IT sector, including TCS, Infosys, LTIMindtree, and Happiest Minds.
  • Q1 results preview suggests that Persistent and Latent View in midcap IT are expected to show strong growth followed by First Source and Happiest Minds.
  • Cross-currency tailwinds are projected to boost dollar revenue growth in non-US regions for IT companies like TCS, Tech Mahindra, Mastek, and KPIT.
  • The article points towards a narrowing growth differential between top-six and midcap IT companies in the second half of FY26.

Read Full Article

like

22 Likes

source image

Eu-Startups

1w

read

229

img
dot

Dutch dental innovator Novenda Technologies secures €5.2 million to further dental products with 3D printing

  • Dutch dental innovator Novenda Technologies secures €5.2 million in Series A funding to enhance dental product manufacturing with multi-material 3D printing technology.
  • The funding round, led by Brightlands Venture Partners, aims to expand Novenda's platform to other dental applications and enable more comfortable and natural-looking dental products.
  • Novenda's technology combines hard materials for protection with soft materials for comfort, using water-soluble supports for seamless multi-material printing and minimal post-processing.
  • The company plans to deploy its technology in dental labs across Europe and the US, focusing on high-throughput, automated solutions to meet growing demand in the dental industry.

Read Full Article

like

13 Likes

For uninterrupted reading, download the app